Marigold Therapeutics, Inc.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Novel drug development in the fields of oncology, autoimmune diseases, and metabolic disorders
The content above was translated by Ai
Founded Year
2024
Unified Business No.
00173792
Status
Active
Number of Employees
0
Total Paid-in
Capital
253,020,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Marigold Therapeutics, Inc. is a startup company based in the National Biotechnology Research Park, focusing on the development of next-generation antibody-drug conjugates (ADCs) to meet various unmet clinical needs, and is dedicated to developing various innovative conjugate drugs to provide patients with better clinical benefits, ultimately aiming to enable patients to have a better quality of life.
The content above was translated by Ai
